Clinical Trial Update: Impact on Glycemic Variability in Newly Onset T2DM Patients Initiating Dapagliflozin Plus Metformin Versus Metformin Alone [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether adding dapagliflozin to metformin improves glycemic variability compared with metformin alone in newly diagnosed type 2 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)
• metformin (metformin)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2025-05-22